Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
02/2001
02/01/2001WO2001007414A1 Preparation of compounds useful for the detection of hypoxia
02/01/2001WO2001007403A1 Naphthyl-substituted sulfonamides
02/01/2001WO2001007402A1 Antiviral agents
02/01/2001WO2001007044A1 Small molecules useful in the treatment of inflammatory disease
02/01/2001WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
02/01/2001DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production
01/2001
01/31/2001EP1072591A1 Novel urea derivatives
01/31/2001EP1072588A1 Process for producing arylsulfenyl halide
01/31/2001EP1072576A1 Fluorinating agent, process for producing the same, and use thereof
01/31/2001EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
01/31/2001EP1071670A1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments
01/31/2001EP1071655A1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
01/31/2001EP0768884B1 Drugs containing a synergistic mixture of metronidazole and clindamycin
01/31/2001CN1282319A Aminobutanoic acid derivatives
01/31/2001CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors
01/31/2001CN1282251A Method and material for treating and preventing mucosal tissue inflammation
01/31/2001CN1281852A 三唑及咪唑衍生物 Triazole and imidazole derivatives
01/31/2001CN1061347C 抗真菌剂 Antifungal agents
01/30/2001US6180796 Sulfonamide derivatives
01/30/2001US6180676 Guanylhydrazones and their use to treat inflammatory conditions
01/30/2001US6180568 Herbicides, miticides, insecticides
01/30/2001US6180116 Histidine derivatives, preparation process and uses
01/30/2001US6179906 Cyclic urea surfactants
01/25/2001WO2001005767A1 Organic compounds
01/25/2001WO2001005756A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
01/25/2001WO2001005753A1 Diacylhydrazine derivatives
01/25/2001WO2001005400A1 Nitroimidazole external preparations for dermatosis
01/25/2001WO2000058293A3 Glucokinase activators
01/25/2001DE19934394A1 New N-phenylnaphthalenesulfonamide derivatives useful for treatment and prevention of viral infection, especially cytomegalovirus
01/25/2001DE19934321A1 New N-phenyl-naphthalenesulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections
01/25/2001DE19934231A1 Verfahren zur Herstellung von 1-substituierten 5-Hydroxy-imidazolin-2,4-dionen und 1-substituierten 5-Alkoxy-imidazolin-2,4-dionen A process for preparing 1-substituted 5-hydroxy-imidazoline-2,4-diones and 1-substituted 5-alkoxy-imidazoline-2,4-diones
01/25/2001CA2379041A1 Diacylhydrazine derivatives
01/24/2001EP1070708A1 Triazole and imidazole derivatives
01/24/2001EP1070706A1 Process for the preparation of 1-substituted 5-hydroxy-imidazolin-2,4-diones and 1-substituted 5-alkoxy-imidazolin-2,4-diones
01/24/2001EP1070046A1 Propanolamine derivatives
01/24/2001EP1069893A2 Use of dexmedetomidine for icu sedation
01/24/2001EP0837852B1 Pesticidal sulfur compounds
01/24/2001CN1281444A Azulene hydroxamic acid derivatives as metalloprotein inhibitors
01/24/2001CN1281438A Piperazine compounds and medical use thereof
01/24/2001CN1281430A N-alkanoylphenylalanine derivatives
01/24/2001CN1281426A Apoptosis inducer
01/24/2001CN1280818A Application of ring enamine as light stability agent
01/24/2001CN1061042C Adhesion receptor antagonists
01/24/2001CN1061038C Hydrophobic liquid salts, preparation thereof and their application in electrochemistry
01/23/2001US6177575 Contacting in the liquid phase ammonium carbonate or ammonium bicarbonate, a glyoxal, an aldehyde, and optionally an amine
01/23/2001US6177466 Matrix metalloproteinase inhibitors
01/23/2001US6177463 Oxime derivatives and their use as pesticides
01/23/2001US6177459 Substituted heterocyclic compounds and their use as fungicides
01/23/2001US6177454 Antidiabetic agents
01/23/2001US6177453 Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
01/23/2001US6177432 Farnesyltransferase inhibiting quinazolinones
01/21/2001CA2314040A1 Process for preparing 1-substituted 5-hydroxy-imidazoline-2,4-diones and 1-substituted 5-alkoxy-imidazoline-2,4-diones
01/18/2001WO2001004098A1 Process of making imidazolidine-2-one derivatives
01/18/2001WO2001004097A2 Cyclic delocalized cations connected by spacer groups
01/18/2001WO1999064049A9 Novel antibacterial agents
01/18/2001DE19932796A1 Diacylhydrazinderivate Diacylhydrazinderivate
01/17/2001EP1069110A1 Sulfonamide derivatives
01/17/2001EP1069107A1 Fullerene derivatives
01/17/2001EP1068200A1 2,4,4-trisubstituted-1,3-dioxolane antifungals
01/17/2001EP1068196A1 Nitrate salt of anti-ulcer medicine
01/17/2001EP1068192A1 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol
01/17/2001EP1068188A1 Novel nucleic acid transfer agents, compositions containing same and uses
01/17/2001EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds
01/17/2001EP0977740A4 Methods for synthesizing 2-substituted imidazoles
01/17/2001EP0721944B1 Imidazolidine derivative and use thereof
01/17/2001CN1280588A Catalyst and method for trimerization of isocyanates
01/17/2001CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
01/17/2001CN1280560A Adamantane derivatives
01/17/2001CN1060774C Process for preparation of enantionerically pure imidazolyl compounds
01/16/2001US6175019 Process for the preparation of 1,3-dimethylimidazolium 4-carboxylate
01/16/2001US6175014 Process for the preparation of lactam derivatives
01/16/2001US6175013 1-(2-methoxybenzyl)-2-((4-phenyl-1-piperazinyl)methyl)-4-(1h -indol-3-ylmethyl)-2-imidazoline, for example; adminstering to treat anxiety, depression, psychosis, and schizophrenia
01/16/2001US6174985 Epoxy resins with N-ester substituted imidazoles
01/16/2001US6174915 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
01/16/2001US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma
01/16/2001US6174904 Treating glycometabolism disorders in mammals by administering therapeutically effective amount of an insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor
01/16/2001US6174885 Improvement or prevention of hair loss in mammals and, in particular, in human
01/16/2001US6174839 As herbicide
01/11/2001WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors
01/11/2001WO2001002370A1 Nickel-based reagents for detecting dna and dna-protein contacts
01/11/2001WO2001002354A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same
01/11/2001WO2001002342A1 2-aminoindane analogs
01/11/2001WO2001002340A2 Novel aminoindanes
01/11/2001WO2000054729A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/11/2001WO2000053596A3 Imidazole compounds as histamine h3 ligands
01/11/2001CA2376476A1 2-aminoindane analogs
01/11/2001CA2376470A1 Novel aminoindanes
01/10/2001EP1066279A1 Imidazolone anorectic agents: ii. phenyl derivatives
01/10/2001EP1066278A1 Imidazolone anorectic agents: iii. heteroaryl derivatives
01/10/2001EP1066264A2 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods
01/10/2001EP1066263A1 Novel cationic 2-acylaminophenols, their use as coupler for oxidation dyeing, compositions containing them, and dyeing methods
01/10/2001EP1066262A1 Imidazolone anorectic agents: i. acyclic derivatives
01/10/2001EP1066246A1 Novel cationic couplers and their use for oxidation dyeing
01/10/2001EP1066022A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
01/10/2001EP1066017A1 Use of retinoic acid activity inhibitors to slow down hair loss
01/10/2001CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof
01/10/2001CN1060471C Process for preparing 4-methylimidazole
01/10/2001CN1060470C Process for preparing 4-methylimidazole
01/09/2001US6172239 Psychological, nervous system disorders
01/09/2001US6172238 Process for manufacturing 1-[3-cyclopentyl-2(R)-[1(R)-hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperidine